Trials / Sponsors / Actinogen Medical
Actinogen Medical
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease Dementia Moderate, Dementia, Mild, Alzheimer Disease | Phase 2 / Phase 3 | 2024-04-12 |
| Completed | Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD) Major Depressive Disorder, MDD, Cognitive Impairment | Phase 2 | 2022-11-28 |
| Completed | A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers Mild Cognitive Impairment, Alzheimer's Disease | Phase 1 / Phase 2 | 2021-06-30 |
| Completed | Xanamem™ in Healthy Elderly Subjects Safety, Peripheral Neuropathy, Cortisol | Phase 1 | 2019-01-21 |
| Completed | A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Du Dementia, Alzheimer Type | Phase 2 | 2017-03-23 |
| Completed | Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects Healthy Volunteers | Phase 1 | 2015-02-01 |